{"id":55773,"date":"2023-04-13T12:06:43","date_gmt":"2023-04-13T10:06:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/"},"modified":"2023-04-13T12:06:43","modified_gmt":"2023-04-13T10:06:43","slug":"monroe-capital-supports-alpine-investors-acquisition-of-medusind","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/","title":{"rendered":"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind"},"content":{"rendered":"
\n

CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC announced it acted as administrative agent and joint lead arranger on the funding of a senior credit facility to support the acquisition of Medusind by private equity sponsor Alpine Investors.<\/p>\n

<\/a><\/p>\n

\nFounded in 2002 and based in Miami, Florida, Medusind is a leading provider of technology solutions and revenue cycle management services to physicians and clients in the healthcare industry. The company provides expertise and revenue cycle management (\u201cRCM\u201d) solutions to dental, anesthesia, pathology, emergency, surgery, radiology, and other specialties. Medusind\u2019s proprietary technology platforms allows its customers to deliver superior outcomes to healthcare provider practices.<\/p>\n

\nAbout Monroe Capital<\/b><\/p>\n

\nMonroe Capital LLC (\u201cMonroe\u201d) is a premier boutique asset management firm specializing in private credit markets across various strategies, including direct lending, asset-based lending, specialty finance, opportunistic, real estate, structured credit, and equity. Since 2004, the firm has been successfully providing capital solutions to clients in the U.S. and Canada. Monroe prides itself on being a value-added and user-friendly partner to business owners, management, and both private equity and independent sponsors. Monroe\u2019s platform offers a wide variety of investment products for both institutional and high net worth investors with a focus on generating high quality \u201calpha\u201d returns irrespective of business or economic cycles. The firm is headquartered in Chicago and maintains offices in Atlanta, Boston, Los Angeles, Miami, Naples, New York, San Francisco, and Seoul.<\/p>\n

\nMonroe has been recognized by both its peers and investors with various awards including Private Debt Investor as the 2022 Lower Mid-Market Lender of the Year, 2022 CLO Manager of the Year, Americas; 2022 Best Performance in Private Debt \u2013 Mid Cap by Korean Economic Daily; Global M&A Network as the 2022 Small Mid-Markets Lender of the Year, Americas; Creditflux as the 2021 Best U.S. Direct Lending Fund; and Pension Bridge as the 2020 Private Credit Strategy of the Year. For more information and important disclaimers, please visit www.monroecap.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nFor more information, please contact:<\/b>
Zia Uddin
\n
Monroe Capital LLC
\n
312-523-2374
\n
zuddin@monroecap.com<\/a><\/p>\n

\nDaniel Abramson
\n
BackBay Communications
\n
857-305-8441
\n
daniel.abramson@backbaycommunications.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC announced it acted as administrative agent and joint lead arranger on the funding of a senior credit facility to support the acquisition of Medusind by private equity sponsor Alpine Investors. Founded in 2002 and based in Miami, Florida, Medusind is a leading provider of technology solutions and revenue cycle management services … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55773","6":"format-standard","7":"category-industry"},"yoast_head":"\nMonroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC announced it acted as administrative agent and joint lead arranger on the funding of a senior credit facility to support the acquisition of Medusind by private equity sponsor Alpine Investors. Founded in 2002 and based in Miami, Florida, Medusind is a leading provider of technology solutions and revenue cycle management services ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-13T10:06:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230413005194\/en\/637629\/21\/Monroe_Capital_Logo_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind\",\"datePublished\":\"2023-04-13T10:06:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/\"},\"wordCount\":350,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005194\\\/en\\\/637629\\\/21\\\/Monroe_Capital_Logo_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/\",\"name\":\"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005194\\\/en\\\/637629\\\/21\\\/Monroe_Capital_Logo_RGB.jpg\",\"datePublished\":\"2023-04-13T10:06:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005194\\\/en\\\/637629\\\/21\\\/Monroe_Capital_Logo_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005194\\\/en\\\/637629\\\/21\\\/Monroe_Capital_Logo_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/","og_locale":"en_US","og_type":"article","og_title":"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind - Pharma Trend","og_description":"CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC announced it acted as administrative agent and joint lead arranger on the funding of a senior credit facility to support the acquisition of Medusind by private equity sponsor Alpine Investors. Founded in 2002 and based in Miami, Florida, Medusind is a leading provider of technology solutions and revenue cycle management services ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-13T10:06:43+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230413005194\/en\/637629\/21\/Monroe_Capital_Logo_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind","datePublished":"2023-04-13T10:06:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/"},"wordCount":350,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005194\/en\/637629\/21\/Monroe_Capital_Logo_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/","url":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/","name":"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005194\/en\/637629\/21\/Monroe_Capital_Logo_RGB.jpg","datePublished":"2023-04-13T10:06:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230413005194\/en\/637629\/21\/Monroe_Capital_Logo_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230413005194\/en\/637629\/21\/Monroe_Capital_Logo_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/monroe-capital-supports-alpine-investors-acquisition-of-medusind\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Monroe Capital Supports Alpine Investors\u2019 Acquisition of Medusind"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55773"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55773\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55773"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}